Characterization of Immunoglobulin G and Its Subclass Response to Indian Kala-Azar Infection before and after Chemotherapy

Infection and Immunity

Volumn 72, Issue 2, 2004, Pages 863-870

  Ravindran, Rajesh ^a   Anam, Khairul ^a,c   Bairagi, Bibhas C ^b   Saha, Bibhuti ^b   Pramanik, Netai ^b   Guha, Subhasis K ^b   Goswami, Rama P ^b   Banerjee, Dwijadas ^b   Ali, Nahid ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b CALCUTTA SCHOOL OF TROPICAL MEDICINE   (India)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMONY GLUCONATE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; LEISHMANIA DONOVANI MEMBRANE ANTIGEN; LIPOSOME; PARASITE ANTIGEN; POLYPEPTIDE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; LABORATORY TEST; LEISHMANIA; LEISHMANIA DONOVANI; LEISHMANIASIS; NONHUMAN; PARASITE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SEROLOGY; TREATMENT OUTCOME; WESTERN BLOTTING;

ADOLESCENT; ADULT; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CHILD; HUMANS; IMMUNOBLOTTING; IMMUNOGLOBULIN G; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; LIPOSOMES; MIDDLE AGED; MOLECULAR WEIGHT;

EID: 0842304736     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.2.863-870.2004     Document Type: Article

References (65)

1. Abbas, A. K., K. M. Murphy, and A. Sher. 1996. Functional diversity of helper T lymphocytes. Nature 383:787-793.
2. Afonso, L. C. C., T. M. Scharton, L. Q. Vieira, M. Wysocka, G. Trincheri, and P. Scott. 1994. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 263:235-237.
3. Afrin, F., and N. Ali. 1997. Adjuvanicity and protective immunity elicited by Leishmania donovani antigens encapsulated in positively charged liposomes. Infect. Immun. 65:2371-2377.
4. Afrin, F., R. Rajesh, K. Anam, M. Gopinath, S. Pal, and N. Ali. 2002. Characterization of Leishmania donovani antigens encapsulated in liposomes that induce protective immunity in BALB/c mice. Infect. Immun. 70:6697-6706.
5. Ali, N., and F. Afrin. 1997. Protection of mice against visceral leishmaniasis by immunization with promastigote antigen incorporated in liposomes. J. Parasitol. 83:70-75.
6. Alvar, J., C. Cañavate, B. Gutiérrez-Solar, M. Jiménez, F. Laguna, R. Lopez-Vélez R. Molina, and J. Moreno. 1997. Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clin. Microbiol. Rev. 10:298-319.
7. Anam, K., F. Afrin, D. Banerjee, N. Pramanik, S. K. Guha, R. P. Goswami, P. N. Gupta, S. K. Saha, and N. Ali. 1999. Immunoglobulin subclass distribution and diagnostic value of Leishmania donovani antigen-specific immunoglobulin G3 in Indian kala-azar patients. Clin. Diagn. Lab. Immunol. 6:231-235.
8. Anam, K., F. Afrin, D. Banerjee, N. Pramanik, S. K. Guha, R. P. Goswami, S. K. Saha, and N. Ali. 1999. Differential decline in Leishmania membrane antigen-specific immunoglobulin G (IgG), IgM, IgE, and IgG subclass antibodies in Indian kala-azar patients after chemotherapy. Infect. Immun. 67: 6663-6669.
9. Arora, S. K., and S. Sehgal. 1989. Identification of major antigens of Leishmania donovani using kala-azar sera. Med. Microbiol. Immunol. 178:81-88.
10. Atta, A. M., A. D'Oliviera, Jr., J. Correa, M. L. B. Atta, R. P. Almeida, and E. M. Carvalho. 1998. Anti-leishmanial IgE antibodies: a marker of active disease in visceral leishmaniasis. Am. J. Trop. Med. Hyg. 59:426-430.
11. Bahrenscheer, J., M. Kemp, J. A. L. Kurtzhals, G. S. Gachihi, A. Kharazmi, and T. G. Theander. 1995. Interferon-γ and interleukin-4 production by human T cells recognizing Leishmania donovani antigens separated by SDS-PAGE. APMIS 103:131-139.
12. Carvalho, E. M., O. Bacellar, C. Brownell, T. Regis, R. L. Coffman, and S. G. Reed. 1994. Restoration of IFN-γ production and lymphocyte proliferation in visceral leishmaniasis. J. Immunol. 152:5949-5956.
13. Carvalho, E. M., R. Badaro, S. G. Reed, T. C. Jones, and W. D. Johnson, Jr. 1985. Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis. J. Clin. Investig. 76:2066-2069.
14. Casadevall, A. 1998. Antibody-mediated protection against intracellular pathogens. Trends Microbiol. 6:102-106.
15. Cenini, P., N. Berhe, A. Hailu, K. McGinnes, and D. Frommel. 1993. Mononuclear cell subpopulations and cytokine levels in human visceral leishmaniasis before and after chemotherapy. J. Infect. Dis. 168:986-993.
16. Cillari, E., F. Y. Liew, P. L. Campo, S. Milano, S. Mansueto, and A. Salerno. 1988. Suppression of IL-2 production by cryopreserved peripheral blood mononuclear cells from patients with active visceral leishmaniasis in Sicily. J. Immunol. 140:2721-2726.
17. da Matta, V. R., S. Hoshino-Shimizu, R. Dietze, and C. E. P. Corbett. 2000. Detection of specific antibody isotypes and subtypes before and after treatment of American visceral leishmaniasis. J. Clin. Lab. Anal. 14:5-12.
18. Desjeux, P. 1992. Human leishmaniasis: epidemiology and public health aspects. World Health Stat. Q. 45:267-275.
19. Dos Santos, J. I., M. G. Morgado, and B. Galvao-Castro. 1987. Human visceral leishmaniasis: analysis of the specificity of humoral immune response to polypeptides of Leishmania donovani chagasi. Am. J. Trop. Med. Hyg. 37:263-270.
20. El Assad, A. M. S., S. A. Younis, M. Siddig, J. Grayson, E. Petersen, and H. W. Ghalib. 1994. The significance of blood levels of IgM, IgA, IgG and IgG subclasses in Sudanese visceral leishmaniasis patients. Clin. Exp. Immunol. 95:294-299.
21. Evans, T. G., E. C. Krug, M. E. Wilson, A. W. Vasconcelos, J. E. de Alencar, and R. D. Pearson. 1989. Evaluation of antibody responses in American visceral leishmaniasis by ELISA and immunoblot. Mem. Inst. Oswaldo Cruz 84:157-166.
22. Ghalib, H. W., M. R. Piuvezam, Y. A. Skeeiky, M. Siddig, F. A. Hashim, A. M. el-Hassan, D. M. Russo, and S. G. Reed. 1993. Interleukin-10 production correlates with pathology in human Leishmania donovani infections. J. Clin. Investig. 92:324-329.
23. Ghosh, A. K., S. Dasgupta, and A. C. Ghose. 1995. Immunoglobulin G subclass-specific antileishmanial antibody responses in Indian kala-azar and post-kala-azar dermal leishmaniasis. Clin. Diagn. Lab. Immunol. 2:291-296.
24. Hailu, A., J. N. Menon, N. Berhe, L. Gedamu, T. H. Hassard, P. A. Kager, J. Olobo, and P. A. Bretscher. 2001. Distinct immunity in patients with visceral leishmaniasis from that in subclinically infected and drug-cured people: implications for the mechanism underlying drug cure. J. Infect. Dis. 184: 112-115.
25. Haldar, J. P., S. Ghose, K. C. Saha, and A. C. Ghose. 1983. Cell-mediated immune response in Indian kala-azar and post-kala-azar dermal leishmaniasis. Infect. Immun. 42:702-707.
26. Heinzel, F. P., M. D. Sadick, B. J. Holaday, R. L. Coffman, and R. M. Locksley. 1989. Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J. Exp. Med. 169:59-72.
27. + lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc. Natl. Acad. Sci. USA 88:7011-7015.
28. Holaday, B. J., M. M. Pompeu, S. Jeronimo, M. J. Texeira, A. A. de Sousa, A. W. Vasconcelos, R. D. Pearson, J. S. Abrams, and R. M. Locksley. 1993. Potential role for interleukin-10 in the immunosupression associated with kala-azar. J. Clin. Investig. 92:2626-2632.
29. Jaffe, C. L., and M. Zallis. 1988. Purification of two Leishmania donovani membrane proteins recognized by sera from patients with visceral leishmaniasis. Mol. Biochem. Parasitol. 27:53-63.
30. Jaffe, C. L., R. Shor, H. Trau, and J. H. Passwell. 1990. Parasite antigens recognized by patients with cutaneous leishmaniasis. Clin. Exp. Immunol. 80:77-82.
31. Karp, C. L., S. H. el-Safi, T. A. Wynn, M. M. H. Satti, A. M. Kordofani, F. A. Hashim, M. Hag-Ali, F. A. Neva, T. B. Nutman, and D. L. Sacks. 1993. In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma. J. Clin. Investig. 91:1644-1648.
32. Kaye, P. M., A. J. Curry, and J. M. Blackwell. 1991. Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine induced rate of cure in murine visceral leishmaniasis. J. Immunol. 146:2763-2770.
33. Kemp, M., J. A. L. Kurtzhals, K. Bendtzen, L. K. Poulsen, M. B. Hansen, D. K. Koech, A. Kharazmi, and T. G. Theander. 1993. Leishmania donovani reactive Th1- and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasis. Infect. Immun. 61:1069-1073.
34. Kenny, R. T., D. L. Sacks, A. A. Gam, H. W. Murray, and S. Sundar. 1998. Splenic cytokine responses in Indian kala-azar before and after treatment. J. Infect. Dis. 177:815-819.
35. Kurtzhals, J. A. L., A. S. Hey, T. G. Theander, E. Odera, C. B. V. Christensen, J. I. Githure, D. K. Koech, K. U. Schaefer, E. Handman, and A. Kharazmi. 1992. Cellular and humoral immune responses in a population from the Baringo district, Kenya, to Leishmania promastigote lipophosphoglycan. Am. J. Trop. Med. Hyg. 46:480-488.
36. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
37. Lepay, D. A., N. Nogueira, and Z. Cohn. 1983. Surface antigens of Leishmania donovani promastigotes. J. Exp. Med. 157:1562-1572.
38. Li, J. S., and G. M. Winslow. 2003. Survival, replication, and antibody susceptibility of Ehrlichia chaffeensis outside of host cells. Infect. Immun. 71:4229-4237.
39. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:265-275.
40. Manson-Bahr, P. E. C. 1961. Immunity in kala-azar. Trans. R. Soc. Trop. Med. Hyg. 55:550-555.
41. Mary, C., D. Lamouroux, S. Dunan, and M. Quilici. 1992. Western blot analysis of antibodies to Leishmania infantum antigens: potential of the 14-kD and 16-kD antigens for diagnosis and epidemiological purposes. Am. J. Trop. Med. Hyg. 47:764-771.
42. Mazumder, S., T. Mukerjee, J. Ghosh, M. Ray, and A. Bhaduri. 1992. Allosteric modulation of Leishmania donovani plasma membrane Ca(2+)-ATPase by endogenous calmodulin. J. Biol. Chem. 267:18440-18446.
43. Miralles, G. D., M. Y. Stoeckle, D. F. McDermott, F. D. Finkelman, and H. W. Murray. 1994. Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis. Infect. Immun. 62:1058-1063.
44. Moore, T. C., O. Ekworommadu, F. O. Eko, L. MacMillan, K. Ramey, G. A. Ananaba, J. W. Patrickson, P. R. Nagappan, D. Lyn, C. M. Black, and J. U. Igietseme. 2003. Fc receptor mediated antibody regulation of T cell immunity against intracellular pathogens. J. Infect. Dis. 188:617-624.
45. Okongo-Odera, E. A., J. A. L. Kurtzhals, A. S. Hey, and A. Kharazmi. 1993. Measurement of serum antibodies against native Leishmania gp63 distinguishes between ongoing and previous L. donovani infection. APMIS 101: 642-646.
46. Raziuddin, S., R. E. Abdalla, E. H. el-Awad, and M. al-Janadi. 1994. Immunoregulatory and proinflammatory cytokine production in visceral and cutaneous leishmaniasis. J. Infect. Dis. 170:1037-1040.
47. Reed, S. G., and P. Scott. 1993. T-cell and cytokine response in leishmaniasis. Curr. Opin. Immunol. 5:524-531.
48. Reed, S. G., R. Badaro, and R. M. C. Lloyd. 1987. Identification of specific and cross-reactive antigens of Leishmania donovani chagasi by human infection sera. J. Immunol. 138:1596-1601.
49. Reed, S. G., W. G. Shreffler, J. M. Burns, Jr., J. M. Scott, M. G. Orge, H. W. Ghalib, M. Siddig, and R. Badaro. 1990. An improved serodiagnosis procedure for visceral leishmaniasis. Am. J. Trop. Med. Hyg. 43:632-639.
50. Rolland, L., V. Zilberfarb, A. Furtado, and M. Gentilini. 1994. Identification of a 94-kilodalton antigen on canine visceral leishmaniasis. Parasite Immunol. 16:599-608.
51. Rolland-Burger, L., X. Rolland, C. W. Grieve, and L. Monjour. 1991. Immunoblot analysis of the humoral immune response to Leishmania donovani infantum polypeptides in human visceral leishmaniasis. J. Clin. Microbiol. 29:1429-1435.
52. Rothman, P., and R. L. Coffman. 1996. Immunoglobulin heavy chain classs-witching, p. 19.1-19.4. In L. A. Herzenberg (ed.), Weir's handbook of experimental immunology, 5th ed. Blackwell Scientific Publications, Oxford, United Kingdom.
53. Russell, D. G., and H. Wilhelm. 1986. The involvement of the major surface glycoprotein (gp63) of Leishmania promastigotes in attachment to macrophages. J. Immunol. 136:2613-2620.
54. Russo, D. M., A. Jardim, E. M. Carvalho, P. R. Sleath, R. J. Armitage, R. W. Olafson, and S. G. Reed. 1993. Mapping human T cell epitopes in Leishmania gp63. J. Immunol. 150:932-939.
55. Ryan, J. R., A. M. Smithyman, G.-H. Rajasekariah, L. Hochberg, J. M. Stiteler, and S. K. Martin. 2002. Enzyme-linked immunosorbent assay based on soluble promastigote antigen detects immunoglobulin M (IgM) and IgG antibodies in sera from cases of visceral and cutaneous leishmaniasis. J. Clin. Microbiol. 40:1037-1043.
56. Sacks, D. L., S. L. Lal, S. N. Shrivastava, J. Blackwell, and F. A. Neva. 1987. An analysis of T cell responsiveness in Indian kala-azar. J. Immunol. 138: 908-913.
57. Salotra, P., A. Raina, and V. Ramesh. 1999. Western blot analysis of humoral immune response to Leishmania donovani antigens in patients with post kala-azar dermal leishmaniasis. Trans. R. Soc. Trop. Med. Hyg. 93:98-101.
58. Shiddo, S. A., G. Huldt, L.-A. Nilsson, O. Quchterlony, and R. Thorstensson. 1996. Visceral leishmaniasis in Somalia. Significance of IgG subclasses and of IgE response. Immunol. Lett. 50:87-93.
59. Shreffler, W. G., J. M. Burns, Jr., R. Badaro, H. W. Ghalib, L. L. Button, W. R. McMaster, and S. G. Reed. 1993. Antibody responses of visceral leishmaniasis patients to gp63, a major surface glycoprotein of Leishmania species. J. Infect. Dis. 167:426-430.
60. Smrkovski, L. L., and C. L. Larson. 1977. Antigenic cross-reactivity between Mycobacterium bovis (BCG) and Leishmania donovani. Infect. Immun. 18: 561-562.
61. Sundar, S., S. G. Reed, S. Sharma, A. Mehrotra, and H. W. Murray. 1997. Circulating T helper 1 (Th1) cell- and Th2 cell-associated cytokines in Indian patients with visceral leishmaniasis. Am. J. Trop. Med. Hyg. 56:522-525.
62. Tebourski, F., A. El Gaied, H. Louzir, R. Ben Ismail, R. Kammoun, and K. Dellagi. 1994. Identification of an immunodominant 32-kilodalton membrane protein of Leishmania donovani infantum promastigotes suitable for specific diagnosis of Mediterranean visceral leishmaniasis. J. Clin. Microbiol. 32:2474-2480.
63. Uzonna, J. E., G. Wei, D. Yurkowski, and P. Bretscher. 2001. Immune elimination of Leishmania major in mice: implications for immune memory, vaccination, and reactivation disease. J. Immunol. 167:6967-6974.
64. Wray, W., T. Boulikas, V. P. Wray, and R. Hancock. 1981. Silver staining of proteins in polyacrylamide gels. Anal. Biochem. 118:197-203.
65. Zwingenberger, K., G. Harms, C. Pedrosa, S. Omena, B. Sandkamp, and S. K. Neifer. 1990. Determinants of the immune response in visceral leishmaniasis: evidence for the predominance of endogenous interleukin 4 over interferon gamma production. Clin. Immunol. Immunopathol. 57:242-249.